News
- Author:
- Neil Osterweil
Publish date: July 16, 2013
Major finding: Among adults followed for 25 years, low physical activity levels were associated with nearly twofold greater odds of cognitive impa...
News
- Author:
- Neil Osterweil
Publish date: July 15, 2013
Major finding: Among 32 patients with mild cognitive impairment with 64 weeks of follow-up, CHF5074 was associated with significant improvements o...
News
- Author:
- Neil Osterweil
Publish date: July 2, 2013
Major finding: One-year progression-free survival in elderly patients with chronic lymphocytic leukemia and comorbidities was 84% with obinutuzuma...
News
- Author:
- Neil Osterweil
Publish date: July 2, 2013
Major finding: Median progression-free survival was 3.4 months for patients randomized to nintedanib and docetaxel, compared with 2.7 months for p...
News
- Author:
- Neil Osterweil
Publish date: July 2, 2013
Major finding: With temozolomide chemoradiotherapy, 3-year overall survival was 73% for patients with low-grade gliomas and three or more risk fac...
News
- Author:
- Neil Osterweil
Publish date: June 25, 2013
Major finding: There were no significant differences in either overall or progression-free survival in patients with squamous cell carcinomas of t...
News
- Author:
- Neil Osterweil
Publish date: June 24, 2013
Major finding: BEAMing plasma-analysis technology identified secondary KIT mutations in 47% of samples from patients with gastrointestinal stromal...
News
- Author:
- Neil Osterweil
Publish date: June 24, 2013
Major finding: For patients with hematologic malignancies treated with busulfan/fludarabine conditioning, allogeneic bone marrow transplant, and c...
News
- Author:
- Neil Osterweil
Publish date: June 18, 2013
Major finding: Progression-free survival of patients with advanced GIST was 1.8 months following imatinib rechallenge, compared with 0.9 months fo...
News
- Author:
- Neil Osterweil
Publish date: June 11, 2013
Major finding: The overall response rate to a combination of idelalisib and rituximab among patients aged 65 years and older with chronic lymphocy...
News
- Author:
- Neil Osterweil
Publish date: June 10, 2013
Major finding: Five of 16 patients available for 3-month follow-up had a sustained clinical response to the TLR9 agonist DIMS0150, compared with n...
News
- Author:
- Neil Osterweil
Publish date: June 10, 2013
Major finding: In a per-protocol analysis, 78.9% of patients on the 5-aminosalicylic acid agent mesalamine had no recurrent diverticulitis after 4...
News
- Author:
- Neil Osterweil
Publish date: June 7, 2013
Major finding: ASGE criteria for suspected choledocholithiasis had a 75% positive predictive value for high-risk patients, and a 55% PPV for inter...
News
- Author:
- Neil Osterweil
Publish date: June 7, 2013
Major finding: SVR 12 rates were 81.3% in treatment-naive patients with HCV genotype 1 treated with simeprevir/pegylated interferon/ribavirin, and...
News
- Author:
- Neil Osterweil
Publish date: June 5, 2013
Major finding: Among patients with mild acute pancreatitis, there were no cases of organ failure or pancreatic necrosis and no deaths within 30 da...
